Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Candel Therapeutics Inc (NQ: CADL )

6.760 +0.350 (+5.46%)
Streaming Delayed Price Updated: 11:32 AM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 193,455
Open 6.500
Bid (Size) 6.700 (6)
Ask (Size) 6.770 (4)
Prev. Close 6.410
Today's Range 6.250 - 6.830
52wk Range 0.6600 - 11.40
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
From Candel Therapeutics
Via GlobeNewswire
How Is The Market Feeling About Candel Therapeutics?
Via Benzinga

Performance

YTD
+366.21%
+366.21%
1 Month
+286.29%
+286.29%
3 Month
+449.59%
+449.59%
6 Month
+660.40%
+660.40%
1 Year
+397.06%
+397.06%

More News

Read More
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
What's Going On With Candel Therapeutics Stock?
Via Benzinga
Exposures Product Safety
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
From Candel Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors
From Candel Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
What's Going On With Candel Therapeutics Stock On Friday?
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Unusually High Volume Points to Upside in These Stocks
Via MarketBeat
Topics ETFs
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Ford, Candel Therapeutics, Nvidia, Palantir, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
After Brain Cancer Data, Candel Therapeutics' Shares Good News From Pancreatic Cancer Study
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer
From Candel Therapeutics
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Micro-Cap Cancer Focused Candel Therapeutics Highlights Encouraging Data From Brain Tumor Immunotherapy
Via Benzinga
Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma
From Candel Therapeutics
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.